X-101398962-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000169.3(GLA):​c.640-16A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.131 in 1,180,033 control chromosomes in the GnomAD database, including 7,341 homozygotes. There are 50,881 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.13 ( 682 hom., 4319 hem., cov: 23)
Exomes 𝑓: 0.13 ( 6659 hom. 46562 hem. )

Consequence

GLA
NM_000169.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.649

Publications

25 publications found
Variant links:
Genes affected
GLA (HGNC:4296): (galactosidase alpha) This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
RPL36A-HNRNPH2 (HGNC:48349): (RPL36A-HNRNPH2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring ribosomal protein L36a and heterogeneous nuclear ribonucleoprotein H2 (H') genes on chromosome X. The read-through transcript produces a protein with similarity to the protein encoded by the upstream locus, ribosomal protein L36a. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 1 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant X-101398962-T-C is Benign according to our data. Variant chrX-101398962-T-C is described in ClinVar as Benign. ClinVar VariationId is 92559.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.291 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000169.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLA
NM_000169.3
MANE Select
c.640-16A>G
intron
N/ANP_000160.1P06280
GLA
NM_001406747.1
c.763-16A>G
intron
N/ANP_001393676.1A0A3B3IUC4
GLA
NM_001406748.1
c.640-16A>G
intron
N/ANP_001393677.1A0A6Q8PHD1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLA
ENST00000218516.4
TSL:1 MANE Select
c.640-16A>G
intron
N/AENSP00000218516.4P06280
RPL36A-HNRNPH2
ENST00000409170.3
TSL:4
c.300+3505T>C
intron
N/AENSP00000386655.4H7BZ11
GLA
ENST00000649178.1
c.763-16A>G
intron
N/AENSP00000498186.1A0A3B3IUC4

Frequencies

GnomAD3 genomes
AF:
0.128
AC:
14288
AN:
111891
Hom.:
682
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.147
Gnomad AMI
AF:
0.0768
Gnomad AMR
AF:
0.0998
Gnomad ASJ
AF:
0.133
Gnomad EAS
AF:
0.0871
Gnomad SAS
AF:
0.310
Gnomad FIN
AF:
0.0901
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.121
Gnomad OTH
AF:
0.103
GnomAD2 exomes
AF:
0.141
AC:
25883
AN:
183214
AF XY:
0.148
show subpopulations
Gnomad AFR exome
AF:
0.153
Gnomad AMR exome
AF:
0.136
Gnomad ASJ exome
AF:
0.125
Gnomad EAS exome
AF:
0.0849
Gnomad FIN exome
AF:
0.0923
Gnomad NFE exome
AF:
0.120
Gnomad OTH exome
AF:
0.130
GnomAD4 exome
AF:
0.131
AC:
139866
AN:
1068089
Hom.:
6659
Cov.:
28
AF XY:
0.138
AC XY:
46562
AN XY:
338483
show subpopulations
African (AFR)
AF:
0.152
AC:
3931
AN:
25805
American (AMR)
AF:
0.131
AC:
4611
AN:
35177
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
2474
AN:
19185
East Asian (EAS)
AF:
0.0815
AC:
2451
AN:
30092
South Asian (SAS)
AF:
0.307
AC:
16385
AN:
53373
European-Finnish (FIN)
AF:
0.0933
AC:
3779
AN:
40485
Middle Eastern (MID)
AF:
0.101
AC:
304
AN:
3016
European-Non Finnish (NFE)
AF:
0.122
AC:
99784
AN:
815876
Other (OTH)
AF:
0.136
AC:
6147
AN:
45080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
3539
7078
10618
14157
17696
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3856
7712
11568
15424
19280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.128
AC:
14297
AN:
111944
Hom.:
682
Cov.:
23
AF XY:
0.126
AC XY:
4319
AN XY:
34144
show subpopulations
African (AFR)
AF:
0.148
AC:
4548
AN:
30821
American (AMR)
AF:
0.0998
AC:
1052
AN:
10546
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
353
AN:
2645
East Asian (EAS)
AF:
0.0868
AC:
310
AN:
3571
South Asian (SAS)
AF:
0.309
AC:
829
AN:
2686
European-Finnish (FIN)
AF:
0.0901
AC:
548
AN:
6079
Middle Eastern (MID)
AF:
0.144
AC:
31
AN:
216
European-Non Finnish (NFE)
AF:
0.121
AC:
6416
AN:
53175
Other (OTH)
AF:
0.103
AC:
158
AN:
1528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
469
938
1408
1877
2346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.133
Hom.:
1132
Bravo
AF:
0.129

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
3
Fabry disease (3)
-
-
3
not provided (3)
-
-
1
Hypertrophic cardiomyopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.061
DANN
Benign
0.36
PhyloP100
-0.65
BranchPoint Hunter
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071397; hg19: chrX-100653950; COSMIC: COSV54509030; COSMIC: COSV54509030; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.